🇺🇸 FDA
Patent

US 8119618

Compositions and methods for the treatment of inflammatory diseases

granted A61KA61K31/13A61K31/198

Quick answer

US patent 8119618 (Compositions and methods for the treatment of inflammatory diseases) held by The Board of Regents of the University of Oklahoma expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Oklahoma
Grant date
Tue Feb 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/13, A61K31/198, A61K31/355, A61K31/375